Atricure Stock Market Value
| ATRC Stock | USD 32.90 4.96 13.10% |
| Symbol | AtriCure |
Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.53) | Revenue Per Share | Quarterly Revenue Growth 0.158 | Return On Assets | Return On Equity |
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
AtriCure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AtriCure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AtriCure.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in AtriCure on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding AtriCure or generate 0.0% return on investment in AtriCure over 90 days. AtriCure is related to or competes with Quidel, BioLife Solutions, Kestra Medical, Azenta, 10X Genomics, Novocure, and Xeris Pharmaceuticals. AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and in... More
AtriCure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AtriCure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AtriCure upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.89 | |||
| Information Ratio | 0.0077 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (5.79) | |||
| Potential Upside | 4.34 |
AtriCure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AtriCure's standard deviation. In reality, there are many statistical measures that can use AtriCure historical prices to predict the future AtriCure's volatility.| Risk Adjusted Performance | 0.0365 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0072 | |||
| Treynor Ratio | 0.0869 |
AtriCure February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0365 | |||
| Market Risk Adjusted Performance | 0.0969 | |||
| Mean Deviation | 2.5 | |||
| Semi Deviation | 3.63 | |||
| Downside Deviation | 3.89 | |||
| Coefficient Of Variation | 2759.81 | |||
| Standard Deviation | 3.63 | |||
| Variance | 13.14 | |||
| Information Ratio | 0.0077 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0072 | |||
| Treynor Ratio | 0.0869 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (5.79) | |||
| Potential Upside | 4.34 | |||
| Downside Variance | 15.11 | |||
| Semi Variance | 13.14 | |||
| Expected Short fall | (2.49) | |||
| Skewness | (0.38) | |||
| Kurtosis | 3.39 |
AtriCure Backtested Returns
At this point, AtriCure is very steady. AtriCure secures Sharpe Ratio (or Efficiency) of 0.0185, which signifies that the company had a 0.0185 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for AtriCure, which you can use to evaluate the volatility of the firm. Please confirm AtriCure's Mean Deviation of 2.5, risk adjusted performance of 0.0365, and Downside Deviation of 3.89 to double-check if the risk estimate we provide is consistent with the expected return of 0.0686%. AtriCure has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.4, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. AtriCure right now shows a risk of 3.71%. Please confirm AtriCure downside variance, and the relationship between the treynor ratio and kurtosis , to decide if AtriCure will be following its price patterns.
Auto-correlation | -0.48 |
Modest reverse predictability
AtriCure has modest reverse predictability. Overlapping area represents the amount of predictability between AtriCure time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AtriCure price movement. The serial correlation of -0.48 indicates that about 48.0% of current AtriCure price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | -0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 3.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out AtriCure Correlation, AtriCure Volatility and AtriCure Performance module to complement your research on AtriCure. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
AtriCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.